Lipinski Jmrc Lecture1 Nov2008
Structural Bioinformatics in Drug Discovery Melissa Passino.
Prioritizing drug targets in complete genomes
Is Brugia malayi’s cofactor-independent phosphoglycerate mutase (iPGM) druggable?
Developing Medicines in Space to Save Lives on Earth
Life Sciences Life Sciences Richard M. Eglen ELRIG, Manchester, UK September 7-8, 2011 High throughput screening and assay development – fit for purpose?
20/03/2008 Dept.of Pharmaceutics 1 Genomics & Proteomics Based Drug DISCOVERY Dr. Basavaraj K. Nanjwade M.Pharm., Ph. D Associate Professor Department.
Drug Design STEPS.pdf
Molecular Biology of Cancer. CANCER TAKES TIME CANCER IS A DISEASE OF GENETIC MUTATIONS ACCUMULATION OF MANY MUTATIONS CAUSES CANCER.
The role of the Italian Medicine Agency (AIFA) Luca Pani, M.D. Director General
Professor Robin Leatherbarrow Head of Biological Chemistry Department of Chemistry.
Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber [email protected].
